A simple blood test measuring inflammation and nutrition levels can predict which heart patients face higher risks after stent surgery. According to Gram Research analysis of 1,513 patients, those with elevated scores had 50% higher risk of death and 59% higher risk of heart-related death within 2-3 years, making this test a practical tool for identifying patients needing closer monitoring.
Researchers studied 1,513 heart patients who had a special procedure to open blocked arteries. They discovered that a simple blood test measuring inflammation and nutrition levels could predict which patients were at higher risk for serious heart problems or death in the years after surgery. According to Gram Research analysis, patients with higher scores on this test were 50% more likely to die and 59% more likely to have heart-related deaths within 2-3 years. This finding could help doctors identify which patients need extra care and monitoring after their procedure.
Key Statistics
A 2026 cohort study of 1,513 patients found that elevated neutrophil percentage-to-albumin ratio was associated with a 50% higher risk of all-cause mortality and 59% higher risk of cardiovascular mortality after successful stent placement for blocked arteries.
In the same study of 1,513 heart patients, adding the blood test score to standard risk assessment improved doctors’ ability to predict death at 1, 2, and 3 years, with improvements of 9.2%, 7.6%, and 5.8% respectively.
Research showed that an optimal blood test cutoff score of 15.7-16.2 identified high-risk patients with 72% sensitivity and 73-76% specificity in predicting adverse outcomes after heart artery procedures.
During median follow-up of 810 days in the 1,513-patient study, 5.5% of patients died from any cause, 3.5% died from heart-related causes, and 4.8% experienced major cardiovascular events like heart attacks or strokes.
The Quick Take
- What they studied: Whether a simple blood test combining inflammation and nutrition markers could predict which heart patients would have serious problems after a procedure to open blocked arteries.
- Who participated: 1,513 patients who had successful stent placement to open completely blocked heart arteries. Patients were followed for about 2.3 years on average.
- Key finding: Patients with higher scores on the blood test had significantly higher risks: 50% increased risk of death, 59% increased risk of heart-related death, and 42% increased risk of major heart events.
- What it means for you: If you’ve had this heart procedure, a simple blood test might help your doctor know if you need extra monitoring or more aggressive treatment to prevent future problems. However, this is one study and should be confirmed with your cardiologist.
The Research Details
This was a cohort study, which means researchers followed a group of patients over time to see what happened to them. They included 1,513 patients who had successfully undergone a procedure called percutaneous coronary intervention (PCI) to open completely blocked heart arteries. The researchers looked back at medical records and calculated a special score for each patient based on two blood test measurements: the percentage of infection-fighting white blood cells (neutrophils) and protein levels (albumin) that indicate nutrition status.
The researchers then tracked these patients for about 2.3 years and recorded serious health events like death, heart attacks, and strokes. They used statistical methods to determine whether the blood test score could predict which patients would have these bad outcomes, even after accounting for other known risk factors like age and heart function.
This research approach is important because it tests whether a simple, inexpensive blood test could help doctors identify high-risk patients who need extra care after heart procedures. Rather than relying on expensive imaging tests, a basic blood test could be done routinely and help guide treatment decisions. The study’s large size (over 1,500 patients) and long follow-up period make the findings more reliable than smaller studies.
This study has several strengths: it included a large number of patients, followed them for a meaningful length of time, and used proper statistical methods to account for other factors that might affect outcomes. However, it was conducted at a single hospital center, so results may not apply equally to all populations. The study was retrospective, meaning researchers looked back at past records rather than prospectively following patients, which can introduce some bias.
What the Results Show
During the follow-up period of about 2.3 years, 83 patients (5.5%) died from any cause, 53 patients (3.5%) died from heart-related causes, and 73 patients (4.8%) experienced major cardiovascular events like heart attacks or strokes. When researchers analyzed the blood test scores, they found a clear pattern: for every increase in the score by one standard deviation, patients had a 50% higher risk of death from any cause, a 59% higher risk of heart-related death, and a 42% higher risk of major cardiovascular events.
The relationship between the blood test score and risk was linear, meaning the risk increased steadily as the score went up—there was no threshold effect where risk suddenly jumped. The researchers identified an optimal cutoff score of about 15.7 to 16.2, where patients above this level had about 72% sensitivity (catching most high-risk patients) and 73-76% specificity (correctly identifying lower-risk patients).
When the blood test score was added to a basic prediction model using age, extent of disease, and heart function, it significantly improved doctors’ ability to predict which patients would die within 1, 2, and 3 years. This improvement was statistically significant and clinically meaningful.
The study found that the blood test score was independently associated with outcomes even after accounting for many other factors known to affect heart health, including age, diabetes, kidney function, and heart pumping ability. The relationship held true across different time periods (1, 2, and 3 years), suggesting the test’s predictive value is stable over time. The optimal cutoff values remained consistent across all three time points, which is important for clinical use.
This is the first study to examine this particular blood test score (neutrophil percentage-to-albumin ratio) in patients who have successfully undergone procedures to open completely blocked arteries. Previous research has shown that inflammation markers and nutritional status separately predict heart outcomes, but this study combines both into one simple score. The findings align with prior research showing that inflammation is a key driver of ongoing heart disease risk even after successful procedures.
The study was conducted at a single hospital, so results may not apply to all populations or healthcare settings. Because it was retrospective, researchers couldn’t control for all factors that might influence outcomes. The study didn’t examine whether changing the blood test score through treatment would improve outcomes. Additionally, the study population may not represent all patients undergoing this procedure, as it was conducted in one center and may reflect specific patient characteristics or treatment practices.
The Bottom Line
If you’ve had a procedure to open a completely blocked heart artery, discuss with your cardiologist whether measuring this blood test score could help guide your treatment. The evidence is strong (from a large study of over 1,500 patients) that higher scores predict worse outcomes, but this should be one tool among many in your care plan. Consider asking your doctor about intensified prevention strategies if your score is elevated, such as more aggressive medication management, lifestyle changes, or closer follow-up appointments.
This research is most relevant to patients who have had procedures to open completely blocked heart arteries and their cardiologists. It may also interest people at high risk for blocked arteries who want to understand predictive markers. This is not relevant to people without heart disease or those who haven’t had this specific procedure. Patients with other types of heart conditions should discuss with their doctors whether these findings apply to them.
The study followed patients for about 2.3 years, so benefits of using this test for risk prediction would be evaluated over months to years, not weeks. If your doctor uses this test to intensify your treatment, you might see benefits in blood pressure control, cholesterol levels, or other markers within weeks to months, but major health outcomes like preventing heart attacks would take longer to assess.
Frequently Asked Questions
What is the neutrophil percentage-to-albumin ratio and why does it matter for heart patients?
It’s a simple blood test score combining two measurements: infection-fighting white blood cells and protein levels. Research shows it predicts which heart patients will have serious problems after stent surgery. Higher scores indicate greater risk of death or heart attacks within 2-3 years.
Can I get this blood test done at my regular doctor’s office?
Yes, the measurements come from standard blood work your doctor already orders. Your doctor can calculate the score from routine neutrophil and albumin values. Ask your cardiologist if they’re using this score to assess your risk after heart procedures.
If my blood test score is high, what should I do?
Discuss with your cardiologist about intensified prevention strategies, which may include more aggressive medication management, stricter lifestyle changes like diet and exercise, and more frequent follow-up appointments. The test identifies risk but doesn’t determine treatment—your doctor will decide the best approach.
How often should I have this blood test done after my heart procedure?
The study doesn’t specify optimal testing frequency, but routine blood work every 3-6 months is typical for heart patients. Ask your cardiologist how often they recommend checking these values based on your individual risk factors and treatment plan.
Does this blood test replace other heart risk assessments?
No, it’s an additional tool that improves prediction when combined with standard assessments like age, heart function, and extent of disease. Your doctor should use it alongside other clinical information, not as a replacement for comprehensive heart disease evaluation.
Want to Apply This Research?
- Track your neutrophil percentage and albumin levels from routine blood work every 3-6 months. Record these values in your health app along with the date and any changes in symptoms or medications. This allows you to monitor trends over time and share data with your cardiologist.
- Use the app to set reminders for blood work appointments every 3-6 months and medication adherence. If your blood test score is elevated, use the app to track lifestyle modifications like daily steps (aim for 150 minutes of moderate activity weekly), dietary sodium intake (under 2,300 mg daily), and medication compliance. Log any chest pain, shortness of breath, or unusual symptoms immediately.
- Create a dashboard showing your blood test values over time with trend lines. Set alerts if values change significantly from baseline. Share quarterly reports with your cardiologist showing your test results alongside lifestyle metrics. Use this data to identify patterns—for example, whether stress, diet, or activity levels correlate with changes in your blood markers.
This research describes an association between a blood test score and heart outcomes in patients who have undergone stent procedures for completely blocked arteries. This information is for educational purposes and should not replace medical advice from your cardiologist. The study was conducted at a single center and should be confirmed in other populations before widespread clinical use. Do not make changes to your heart medications or treatment plan based on this article alone. Always consult with your healthcare provider about your individual risk factors, appropriate testing, and treatment options. If you experience chest pain, shortness of breath, or other cardiac symptoms, seek immediate medical attention.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.